LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Novavax Inc

Închisă

SectorSănătate

7.45 6.43

Rezumat

Modificarea prețului

24h

Curent

Minim

7.34

Maxim

7.47

Indicatori cheie

By Trading Economics

Venit

600M

519M

Vânzări

578M

667M

P/E

Medie Sector

2.571

51.198

EPS

2.93

Marjă de profit

77.798

Angajați

952

EBITDA

569M

516M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+51.01% upside

Dividende

By Dow Jones

Următoarele câștiguri

7 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

130M

1.1B

Deschiderea anterioară

1.02

Închiderea anterioară

7.45

Sentimentul știrilor

By Acuity

50%

50%

166 / 380 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

Novavax Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

2 apr. 2025, 17:06 UTC

Principalele dinamici ale pieței

Novavax Falls But Then Recovers After WSJ Report on Vaccine's FDA Status

31 mar. 2025, 14:19 UTC

Principalele dinamici ale pieței

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

4 feb. 2025, 18:52 UTC

Principalele dinamici ale pieței

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

11 nov. 2024, 14:05 UTC

Principalele dinamici ale pieței

Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold

16 oct. 2024, 12:59 UTC

Principalele dinamici ale pieței

Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines; Shares Drop

19 mai 2025, 14:30 UTC

Top știri

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

19 mai 2025, 13:27 UTC

Top știri

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

8 mai 2025, 17:55 UTC

Câștiguri

Why This Shrinking Covid-19 Vaccine Stock Jumped 30% -- Barrons.com

8 mai 2025, 15:12 UTC

Câștiguri

Why This Shrinking Covid-19 Vaccine Stock Jumped 30% -- Barrons.com

28 apr. 2025, 17:04 UTC

Câștiguri

Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot. -- Barrons.com

30 dec. 2024, 23:02 UTC

Achiziții, Fuziuni, Preluări

Novavax Completes Previously Announced $200M Sale of Czech Republic Manufacturing Site to Novo Nordisk

4 dec. 2024, 07:09 UTC

Achiziții, Fuziuni, Preluări

Novavax: Agreement to Close by Dec 30 >NVAX

4 dec. 2024, 07:08 UTC

Achiziții, Fuziuni, Preluări

Novavax: Sale Aligns With Plan to Become More Lean Organization, Drive Value From Pipeline Assets & Tech Platform >NVAX

4 dec. 2024, 07:07 UTC

Achiziții, Fuziuni, Preluări

Novavax: Deal to Also Reduce Annual Operating Costs by About $80M >NVAX

4 dec. 2024, 07:06 UTC

Achiziții, Fuziuni, Preluări

Novavax to Get $190M Cash Payment in 2024, Additional $10M in 2025 >NVAX

4 dec. 2024, 07:06 UTC

Achiziții, Fuziuni, Preluări

Novavax: Agreement Provides Company With Significant, Non-Dilutive Capital >NVAX

4 dec. 2024, 07:04 UTC

Achiziții, Fuziuni, Preluări

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200M

15 nov. 2024, 13:34 UTC

Top știri

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

15 nov. 2024, 11:14 UTC

Market Talk

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

16 oct. 2024, 15:22 UTC

Câștiguri

These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, DJT, Novavax, J.B. Hunt, Cisco, and More -- Barrons.com

Comparație

Modificare preț

Novavax Inc Așteptări

Obiectiv de preț

By TipRanks

51.01% sus

Prognoză pe 12 luni

Medie 11.25 USD  51.01%

Maxim 19 USD

Minim 7 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruNovavax Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

4 ratings

1

Cumpărare

2

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

5.692 / 6.039Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Weak Bearish Evidence

Sentiment

By Acuity

166 / 380 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.